Oncolytics Biotech faces financial struggles and unclear pelareorep efficacy signals. Learn why ONCY stock's risks outweigh ...
Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn ...
Dr. Sarah M. Tolaney discusses breast practices associated with CDK4/6 inhibitors for the treatment of breast cancer.
Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo ...
Scientists found that aspirin blocks TXA2, freeing T cells to fight cancer. This discovery could help prevent metastasis, but ...
Analysts at HC Wainwright issued their Q3 2025 EPS estimates for Rigel Pharmaceuticals in a research report issued to clients ...
Equities research analysts at B. Riley issued their Q1 2025 EPS estimates for shares of Rigel Pharmaceuticals in a research note issued on Tuesday, March 4th. B. Riley analyst K. Patel expects that ...
UC San Diego researchers have developed a device that predicts breast cancer aggressiveness by measuring tumor cell adhesion. Weakly adherent cells indicate a higher risk of metastasis, especially in ...
Emily Powell-Heaton was eating dinner with a friend when she got a message from Ben Stiller. She tells TODAY.com that her ...
For Colorectal Cancer Awareness Month, Scott Kopetz, MD, PhD, FACP, discussed the BREAKWATER trial in metastatic BRAF ...
The FDA granted its first approval for a systemic therapy for patients with non-small cell lung cancer with an Neuregulin 1 ...
4d
Discover Magazine on MSNAspirin Might Be the Next Big Thing in Fighting the Spread of CancerLearn how a staple from our medicine cabinet has the potential to support the immune system in combating metastatic cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results